<code id='57F4C19EFE'></code><style id='57F4C19EFE'></style>
    • <acronym id='57F4C19EFE'></acronym>
      <center id='57F4C19EFE'><center id='57F4C19EFE'><tfoot id='57F4C19EFE'></tfoot></center><abbr id='57F4C19EFE'><dir id='57F4C19EFE'><tfoot id='57F4C19EFE'></tfoot><noframes id='57F4C19EFE'>

    • <optgroup id='57F4C19EFE'><strike id='57F4C19EFE'><sup id='57F4C19EFE'></sup></strike><code id='57F4C19EFE'></code></optgroup>
        1. <b id='57F4C19EFE'><label id='57F4C19EFE'><select id='57F4C19EFE'><dt id='57F4C19EFE'><span id='57F4C19EFE'></span></dt></select></label></b><u id='57F4C19EFE'></u>
          <i id='57F4C19EFE'><strike id='57F4C19EFE'><tt id='57F4C19EFE'><pre id='57F4C19EFE'></pre></tt></strike></i>

          Home / comprehensive / focus

          focus


          focus

          author:comprehensive    Page View:9
          Boston Scientific headquarters -- Health coverage from STAT
          Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

          Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

          It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

          advertisement

          Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In